Stay updated on Cabozantinib in HR+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in HR+ Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T04:19:01.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T20:09:06.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:25:08.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now includes updated information regarding the modernization of ClinicalTrials.gov data ingest scheduled for June 2025, along with detailed definitions of response rates and survival metrics for a study involving cabozantinib therapy. Additionally, some outdated information has been removed.
    Difference
    30%
    Check dated 2025-05-29T06:12:58.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T16:48:57.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page has undergone significant content changes regarding a clinical trial for cabozantinib in breast cancer treatment, including the removal of detailed drug administration protocols and study criteria, while adding collaborators and a new version revision.
    Difference
    31%
    Check dated 2025-04-16T12:33:04.000Z thumbnail image

Stay in the know with updates to Cabozantinib in HR+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in HR+ Breast Cancer Clinical Trial page.